search
Back to results

Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline (ROSSTAR)

Primary Purpose

Coronary Heart Disease, Coronary Artery Disease

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Observation
Nuclear Perfusion Imaging Stress Test
Sponsored by
Sir Mortimer B. Davis - Jewish General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Heart Disease focused on measuring Myocardial Infarction, Physiological Stress Test, Nuclear Image Perfusion, Angioplasty, Coronary Artery Bypass Graft, Percutaneous Coronary Intervention, Angina, Ischemia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 1.Patients who have undergone CABG or PCI.
  • 2.CABG surgery occurred >5 years and PCI >2 years prior to randomization.
  • 3.Patients must have had at least one SVG in the CABG group.
  • 4.Patients are asymptomatic or have minimal chronic anginal symptoms.

Exclusion Criteria:

  • 1.Participation in a conflicting clinical study.
  • 2.RNI testing already planned or performed within the past 12 months.
  • 3.Unable to give informed consent.
  • 4.Contraindications to or inability to perform exercise treadmill testing or pharmacological testing.
  • 5.Medical condition with a prognosis of less than 3.25 years.
  • 6.Likely to be unavailable for follow-up.
  • 7.Unable to read and understand English or French.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Experimental

    Arm Label

    Observation

    Nuclear Perfusion Imaging Stress Test

    Arm Description

    Patient receives standard observation, i.e. only do a nuclear imaging stress test if symptoms present themselves over the course of 3 years.

    Patient receives routine nuclear image perfusion stress test

    Outcomes

    Primary Outcome Measures

    Combined index (i.e.if any are positive then index is positive)
    Myocardial Infarction, Death,Urgent Hospitalization for Cardiac Reasons

    Secondary Outcome Measures

    Quality of Life
    Difference in scores between baseline and follow-up Seattle Angina Questionnaire

    Full Information

    First Posted
    February 24, 2017
    Last Updated
    March 15, 2017
    Sponsor
    Sir Mortimer B. Davis - Jewish General Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03067402
    Brief Title
    Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline
    Acronym
    ROSSTAR
    Official Title
    Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    March 20, 2017 (Anticipated)
    Primary Completion Date
    June 20, 2021 (Anticipated)
    Study Completion Date
    June 10, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Sir Mortimer B. Davis - Jewish General Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The ROSSTAR trial is a pragmatic trial that will directly compare the strategies of routine and selective stress imaging testing (with radionuclide imaging (RNI)) late after PCI or CABG in asymptomatic patients. The study will be a single center trial based at the Jewish General Hospital (JGH), a McGill University teaching hospital (Montreal, Quebec). A total of 1100 patients who are either >5 years post-CABG or >2 years post-PCI will be randomized. Half of the patients will be randomized to a routine RNI testing, and the other half to selective RNI testing.
    Detailed Description
    There is no consensus in current guidelines regarding the role of stress imaging testing late after revascularization. The issue to be resolved by the trial is whether routine stress imaging testing (stress test with nuclear perfusion imaging) benefits patients late after percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG). What are the principal research questions to be addressed? Is a strategy of routine stress imaging testing late after PCI or CABG associated with lower clinical event rates than a strategy of selective stress imaging testing? Is a strategy of routine stress imaging testing late after PCI or CABG associated with better quality of life than a strategy of selective stress imaging testing? What are the resources utilization associated with routine vs. selective stress imaging testing? What is the primary hypothesis? The primary hypothesis is that routine stress imaging testing late after PCI or CABG is associated with lower clinical event rates than a strategy of selective stress imaging testing.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Coronary Heart Disease, Coronary Artery Disease
    Keywords
    Myocardial Infarction, Physiological Stress Test, Nuclear Image Perfusion, Angioplasty, Coronary Artery Bypass Graft, Percutaneous Coronary Intervention, Angina, Ischemia

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    1100 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Observation
    Arm Type
    Other
    Arm Description
    Patient receives standard observation, i.e. only do a nuclear imaging stress test if symptoms present themselves over the course of 3 years.
    Arm Title
    Nuclear Perfusion Imaging Stress Test
    Arm Type
    Experimental
    Arm Description
    Patient receives routine nuclear image perfusion stress test
    Intervention Type
    Other
    Intervention Name(s)
    Observation
    Intervention Description
    Patient receives standard observation i.e. only do a nuclear imaging stress test if symptoms present themselves over the course of 3 years
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    Nuclear Perfusion Imaging Stress Test
    Intervention Description
    Patient receives routine nuclear image perfusion stress test
    Primary Outcome Measure Information:
    Title
    Combined index (i.e.if any are positive then index is positive)
    Description
    Myocardial Infarction, Death,Urgent Hospitalization for Cardiac Reasons
    Time Frame
    Yearly up to 3 years from date of randomization
    Secondary Outcome Measure Information:
    Title
    Quality of Life
    Description
    Difference in scores between baseline and follow-up Seattle Angina Questionnaire
    Time Frame
    Baseline and yearly up to 3 years from date of randomization
    Other Pre-specified Outcome Measures:
    Title
    Resource Utilization
    Description
    Total number of hospital days for cardiac admissions, further invasive and non-invasive testing, and revascularization procedures
    Time Frame
    Yearly up to 3 years from date of randomization

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 1.Patients who have undergone CABG or PCI. 2.CABG surgery occurred >5 years and PCI >2 years prior to randomization. 3.Patients must have had at least one SVG in the CABG group. 4.Patients are asymptomatic or have minimal chronic anginal symptoms. Exclusion Criteria: 1.Participation in a conflicting clinical study. 2.RNI testing already planned or performed within the past 12 months. 3.Unable to give informed consent. 4.Contraindications to or inability to perform exercise treadmill testing or pharmacological testing. 5.Medical condition with a prognosis of less than 3.25 years. 6.Likely to be unavailable for follow-up. 7.Unable to read and understand English or French.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    David Iannuzzi, MSc
    Phone
    (514)340-8222
    Ext
    26191
    Email
    david.iannuzzi.ccomtl@ssss.gouv.qc.ca
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Dominique Joyal, MD
    Organizational Affiliation
    Interventional Cardiologist, Assistant Professor of Medicine, McGill University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    16226194
    Citation
    Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM, Patel MR, Raskin IE, Hendel RC, Bateman TM, Cerqueira MD, Gibbons RJ, Gillam LD, Gillespie JA, Hendel RC, Iskandrian AE, Jerome SD, Krumholz HM, Messer JV, Spertus JA, Stowers SA; American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American Society of Nuclear Cardiology; American Heart Association. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005 Oct 18;46(8):1587-605. doi: 10.1016/j.jacc.2005.08.029. Erratum In: J Am Coll Cardiol. 2005 Dec 6;46(11):2148-50.
    Results Reference
    background
    PubMed Identifier
    20177011
    Citation
    Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23;121(7):948-54. doi: 10.1161/CIRCULATIONAHA.109.192666. No abstract available. Erratum In: Circulation. 2010 Mar 30;121(12):e259.
    Results Reference
    background
    PubMed Identifier
    19497454
    Citation
    Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009 Jun 9;53(23):2201-29. doi: 10.1016/j.jacc.2009.02.013. No abstract available.
    Results Reference
    background
    PubMed Identifier
    23182125
    Citation
    Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164. doi: 10.1016/j.jacc.2012.07.013. Epub 2012 Nov 19. No abstract available.
    Results Reference
    background

    Learn more about this trial

    Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline

    We'll reach out to this number within 24 hrs